↧
Image may be NSFW.
Clik here to view.
Clik here to view.
Oligonucleotide therapy helps to prevent chronic hepatitis B
GSK has announced study results from its Phase IIb trial (NCT04449029) of bepirovirsen for chronic hepatitis B (CHB), indicating that the antisense oligonucleotide therapy could help treat CHB...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment
New trial results for GSK’s oral gepotidacin, a potential first-in-class oral antibiotic, has shown that it was non-inferior with 92.6 percent success rates in patients with uncomplicated urogenital...
View Article